BioCryst Pharmaceuticals Inc (BCRX) — Financial Flexibility Index
BioCryst Pharmaceuticals Inc (BCRX) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-61.73 Million (operating CF $-62.14 Million minus capex $403.00K) represents 0% of total liabilities ($1.02 Billion). Check BCRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioCryst Pharmaceuticals Inc Financial Flexibility Index (1994–2025)
Historical Financial Flexibility Index trend for BioCryst Pharmaceuticals Inc across 32 annual periods. For the full cash flow conversion analysis, see BCRX cash flow conversion.
Annual Financial Flexibility Index for BioCryst Pharmaceuticals Inc (1994–2025)
Year-by-year free cash flow to debt coverage for BioCryst Pharmaceuticals Inc. Explore BioCryst Pharmaceuticals Inc (BCRX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.52x | $332.35 Million | $329.88 Million | $633.31 Million | ▲ +1096.4% |
| 2024 | -0.05x | $-50.90 Million | $-52.02 Million | $966.35 Million | ▲ +44.9% |
| 2023 | -0.10x | $-92.97 Million | $-95.14 Million | $972.49 Million | ▲ +49.7% |
| 2022 | -0.19x | $-160.50 Million | $-161.85 Million | $844.60 Million | ▲ +5.5% |
| 2021 | -0.20x | $-139.77 Million | $-142.16 Million | $695.14 Million | ▲ +47.9% |
| 2020 | -0.39x | $-136.70 Million | $-137.22 Million | $353.98 Million | ▲ +40.7% |
| 2019 | -0.65x | $-89.24 Million | $-89.58 Million | $137.03 Million | ▲ +31.1% |
| 2018 | -0.94x | $-92.20 Million | $-92.56 Million | $97.61 Million | ▼ -118.7% |
| 2017 | -0.43x | $-40.81 Million | $-41.14 Million | $94.49 Million | ▲ +20.8% |
| 2016 | -0.55x | $-48.16 Million | $-53.44 Million | $88.27 Million | ▼ -424.4% |
| 2015 | -0.10x | $-7.99 Million | $-13.12 Million | $76.83 Million | ▲ +83.4% |
| 2014 | -0.63x | $-38.45 Million | $-38.55 Million | $61.24 Million | ▼ -18.4% |
| 2013 | -0.53x | $-26.50 Million | $-26.53 Million | $49.99 Million | ▲ +17.7% |
| 2012 | -0.64x | $-37.28 Million | $-37.40 Million | $57.89 Million | ▼ -34.8% |
| 2011 | -0.48x | $-32.20 Million | $-32.25 Million | $67.40 Million | ▲ +25.6% |
| 2010 | -0.64x | $-28.23 Million | $-28.55 Million | $43.94 Million | ▼ -130.1% |
| 2009 | -0.28x | $-15.61 Million | $-16.22 Million | $55.92 Million | ▲ +45.7% |
| 2008 | -0.51x | $-19.66 Million | $-20.87 Million | $38.27 Million | ▼ -101.2% |
| 2007 | 42.65x | $3.32 Billion | $-25.00 Million | $77.81 Million | ▲ +14860.5% |
| 2006 | -0.29x | $-13.68 Million | $-15.21 Million | $47.33 Million | ▲ +48.4% |
| 2005 | -0.56x | $-22.85 Million | $-23.35 Million | $40.81 Million | ▲ +90.2% |
| 2004 | -5.70x | $-17.88 Million | $-18.15 Million | $3.13 Million | ▲ +15.6% |
| 2003 | -6.76x | $-11.14 Million | $-11.20 Million | $1.65 Million | ▲ +50.3% |
| 2002 | -13.61x | $-15.96 Million | $-16.36 Million | $1.17 Million | ▼ -311.2% |
| 2001 | -3.31x | $-7.55 Million | $-10.16 Million | $2.28 Million | ▼ -6707.2% |
| 2000 | -0.05x | $-454.34K | $-3.18 Million | $9.35 Million | ▲ +97.5% |
| 1999 | -1.95x | $-3.90 Million | $-4.90 Million | $2.00 Million | ▲ +28.2% |
| 1998 | -2.71x | $-3.80 Million | $-4.20 Million | $1.40 Million | ▲ +64.6% |
| 1997 | -7.67x | $-9.20 Million | $-10.30 Million | $1.20 Million | ▼ -100.5% |
| 1996 | -3.82x | $-6.50 Million | $-6.80 Million | $1.70 Million | ▲ +8.2% |
| 1995 | -4.17x | $-7.50 Million | $-7.70 Million | $1.80 Million | ▼ -9.3% |
| 1994 | -3.81x | $-6.10 Million | $-6.50 Million | $1.60 Million | — |